The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback